A California-based biotech firm turned heads on Wednesday after the company announced that it filed a shelf registration statement for the potential sale of up to $100 million of...

To read the full story on AllPennyStocks.com, click here.

Dermata Therapeutics (NASDAQ:DRMA)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Dermata Therapeutics.
Dermata Therapeutics (NASDAQ:DRMA)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Dermata Therapeutics.